Background: The Framingham Risk Score (FRS) has been shown to be effective in predicting the risk of cardiovascular disease and primary events such as myocardial infarction. However, there is little evidence showing its effective use in predicting secondary events in patients with established coronary artery disease. This study aims to evaluate the utility of the FRS in predicting secondary events in patients following PCI at a tertiary referral center across a 17-year period of time and to ascertain whether there is a change in its utility in predicting secondary events across this time period. Methods: The FRS of 25,519 consecutive patients presenting to the catheterization laboratory at a tertiary referral center between January 1994 and December 2010 was determined (71% male, mean age 66.5+/-12.1, mean score 7.0+/-3.3). Patients were divided into 4 groups depending on their 10-year cardiovascular disease risk (< 5%, 5-10%, 10-20% and >20%) and were followed up for a median duration of 109 months (IQR 63-155) for secondary events including myocardial infarction, death and target-vessel revascularization. The association between FRS and secondary event rate was then assessed. Patients were also separately divided into 5 equal temporal groups depending on the date of PCI and the association between each group's FRS and secondary event rate was assessed and compared between groups. Results: The FRS was shown to be significantly associated with secondary event rate following PCI (p< 0.001) but the differences between risk groups were not large (C-statistic 0.54). To assess for temporal changes in the association between FRS and secondary event rate, the data from the 5 temporal groups was fit to a Cox model with an interaction between FRS and time . The association between FRS and secondary event rate across the different temporal groups did not change significantly (p¼0.10). Conclusions: This study shows that the FRS may be used to predict secondary events in patients following PCI but lacks the ability to discriminate very well between high and low risk patients. The FRS has also been shown to retain its utility in predicting secondary events amongst these patients across different periods of time.
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Impact Background: Pts with prior myocardial infarction (MI) undergoing percutaneous coronary intervention (PCI) are thought to have worse long-term outcomes, but the magnitude of this impact remains unknown. We sought to assess the impact of prior MI on 1-year outcomes in patients undergoing PCI. Methods: Patient-level data from 18 prospective randomized trials (RAVEL, E-SIRIUS, SIRIUS, C-SIRIUS, TAXUS I-II, TAXUS IV-VI, ENDEAVOR II-IV, SPIRIT II-IV, ACUITY, HORIZONS-AMI and COMPARE) were pooled. Pts were stratified by history of prior MI. Adverse ischemic outcomes were compared between the 2 groups at 1 year. Results: Among 31,533 patients, prior MI was present in 8,357 (26.5%) pts. Pts with prior MI were more likely to be male, current smokers and have diabetes, hypertension and hyperlipidemia. Pts with vs. without prior MI had significantly higher 1-year rates of death (3.9% vs. 2.7%, p< 0.0001), cardiac death (2.4% vs. 1.5%, p¼0.0001), subsequent reinfarction (6.8% vs. 4.6%, P< 0.0001), definite/probable stent thrombosis (1.7% vs. 1.1%, p¼0.006), major adverse cardiac events (15.1% vs. 12.5, p< 0.000). By multivariable analysis, prior MI was an independent predictor of death 
